January 2026 Options Now Available For Quest Diagnostics (DGX)

Investors considering Quest Diagnostics (DGX) may find opportunities in options trading, specifically selling put options at a $175 strike price or employing a covered call strategy with a $180 strike price. Selling the $175 put offers a potential 4.63% return if the contract expires worthless, while a covered call at $180 could yield a 7.55% return if the stock is called away; analytical data suggests a 59% and 47% chance, respectively, of these contracts expiring worthless.

Analysis

The analysis focuses on two specific options strategies for Quest Diagnostics (DGX) shares, which are currently trading at $176.66. Selling the $175 strike put contract, with a bid of $8.10, presents an alternative entry point at an effective cost basis of $166.90 per share, representing a discount to the current market price. This strategy has a 59% statistical probability of the option expiring worthless, in which case the seller retains the premium, translating to a 4.63% return on the cash commitment, or an annualized YieldBoost of 7.75%. Alternatively, for existing DGX shareholders, selling a covered call at the $180 strike price with a $10.00 bid could generate a total return of 7.55% if DGX shares are called away at the January 2026 expiration; this calculation includes the premium received. There is a 47% statistical chance this call option expires worthless, allowing the investor to retain their shares and the premium, which would represent a 5.66% yield enhancement, or an annualized YieldBoost of 9.48%. Significantly, the implied volatility of approximately 23% for both the put and call examples closely aligns with Quest Diagnostics' actual trailing twelve-month historical volatility of 22%, suggesting that these options are currently priced in line with recent historical price fluctuations.

Key Decisions for Investors

• Investors interested in acquiring Quest Diagnostics shares or those comfortable with a potential purchase price of $166.90 could consider selling the $175 strike put to either achieve a discounted entry or earn a 4.63% premium (7.75% annualized) if the shares remain above the strike at expiration.
• Current DGX shareholders seeking to generate additional income might evaluate the covered call strategy using the $180 strike, targeting a potential 7.55% total return if the stock is called away by the January 2026 expiration, or a 5.66% premium yield (9.48% annualized) if the option expires worthless, while acknowledging the capped upside potential.
• Given that implied volatility (approximately 23%) is closely aligned with historical volatility (22%), these options strategies appear fairly valued from a volatility standpoint, meaning investment decisions should primarily hinge on an individual's directional outlook for DGX and specific income objectives rather than on exploiting perceived mispricings in volatility.